CBD Med Research Corp. Announces Financing Update

Vancouver, British Columbia--(Newsfile Corp. - April 14, 2015) - Further to the CBD Med Research Corp. (TSXV: CBM.H) ("The Company") news release of February 24, 2015, The Company is pleased to announce it is proceeding with the financing of up to a total raise of  $500,000 by way of a unit private placement.

The company on closing will issue up to a further 6,266,667 units priced at 0.06 cents for general working capital with a one-year warrant exercisable at 0.08cents with a one year term.

The company previously closed the first tranche of $124,000 and issued 2,066,666 units to (11 placees)

Finders Fees may be paid of 8% cash.

The private placement is subject to TSX approval.

On behalf of the Board of Directors,

CBD Med Research Corp.

"Gary F. Zak"
President, CEO

Email: gzak1@shaw.ca
Tel: 604-802-7551

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release includes certain statements that may be deemed "forward-looking statements". All statements in this release, other than statements of historical facts, including the likelihood of commercial mining and possible future financings are forward-looking statements. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in the forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include unsuccessful business , changes in forecast prices, changes in the availability of funding for proposed business plans, unanticipated changes in key management personnel and general economic conditions. Accordingly the actual events may differ materially from those projected in the forward-looking statements. For more information on the Company and the risks and challenges of its business, investors should review the Company's annual filings that are available at www.sedar.com.

*THIS NEWS RELEASE IS NOT FOR DISSEMINATION IN THE UNITED STATES*